AAAAAA

   
Results: 1-21 |
Results: 21
COMPARISON OF HLA-IDENTICAL TRANSPLANTATION OF UNSELECTED BLOOD STEM-CELLS (PBSCT) AND BONE-MARROW (BMT) FROM RELATED DONORS IN PATIENTS WITH HEMATOLOGIC MALIGNANCY - A SINGLE-CENTER REPORT
Authors: KUBEL M LEIBLEIN S PONISCH W SCHULZE E SCHWENKE H KAMPRAD F KRAHL R
Citation: M. Kubel et al., COMPARISON OF HLA-IDENTICAL TRANSPLANTATION OF UNSELECTED BLOOD STEM-CELLS (PBSCT) AND BONE-MARROW (BMT) FROM RELATED DONORS IN PATIENTS WITH HEMATOLOGIC MALIGNANCY - A SINGLE-CENTER REPORT, Bone marrow transplantation, 22, 1998, pp. 1-1
RHG-CSF MOBILIZATION AND COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN HEALTHY DONORS
Authors: PONISCH W LEIBLEIN S EDEL E KUBEL M RIESE F SCHWARZER A SCHWENKE H KIEFEL V HELBIG W
Citation: W. Ponisch et al., RHG-CSF MOBILIZATION AND COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN HEALTHY DONORS, Bone marrow transplantation, 22, 1998, pp. 17-17
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE
Authors: PONISCH W LEIBLEIN S EDEL E SCHWARZER A ULRICH E HAUSTEIN B KRAHL R LEHMANN KT KUBEL M HELBIG W
Citation: W. Ponisch et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE, Bone marrow transplantation, 22, 1998, pp. 19-19
AUTOLOGOUS STEM-CELL TRANSPLANTATION IN CML - LEIPZIG EXPERIENCES
Authors: SCHWARZER A KRAHL R KUBEL M EDEL E LEIBLEIN S PONISCH W ULRICH E LEHMANN KT SCHWENKE H HELBIG W
Citation: A. Schwarzer et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION IN CML - LEIPZIG EXPERIENCES, Bone marrow transplantation, 22, 1998, pp. 26-26
SELECTION OF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS (APBPC) WITH THE CEPRATE SC SYSTEM
Authors: ULRICH ER LEIBLEIN S KUBEL M PONISCH W HELBIG W MEISSNER M EDEL E KIEFEL V
Citation: Er. Ulrich et al., SELECTION OF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS (APBPC) WITH THE CEPRATE SC SYSTEM, Bone marrow transplantation, 22, 1998, pp. 32-32
2ND UNRELATED BONE-MARROW TRANSPLANTATION WITHOUT ADDITIONAL CONDITIONING THERAPY AFTER ENGRAFTMENT FAILURE
Authors: WOLFF D BECKER C KUBEL M PONISCH W EDELMANN J FRIEDRICH T HELBIG W
Citation: D. Wolff et al., 2ND UNRELATED BONE-MARROW TRANSPLANTATION WITHOUT ADDITIONAL CONDITIONING THERAPY AFTER ENGRAFTMENT FAILURE, Bone marrow transplantation, 21(3), 1998, pp. 315-317
TREATMENT OF HIGH-RISK CHRONIC GVHD WITH FK-506 (FK), MYCOPHENOLATEMOFETIL (MMF) AND METHYLPREDNISOLONE
Authors: WOLFF D BECKER C PONISCH W KUBEL M HELBIG W
Citation: D. Wolff et al., TREATMENT OF HIGH-RISK CHRONIC GVHD WITH FK-506 (FK), MYCOPHENOLATEMOFETIL (MMF) AND METHYLPREDNISOLONE, Bone marrow transplantation, 21, 1998, pp. 430-430
TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH FK-506
Authors: WOLFF D BECKER C KURSCHNER D SKIBBE T PONISCH W KUBEL M HELBIG W
Citation: D. Wolff et al., TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH FK-506, Bone marrow transplantation, 21, 1998, pp. 431-431
CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT
Authors: LINK H ARSENIEV L LJUNGMAN P ALESSANDRINO EP AMADORI S BANDINI G BEGUIN Y BRINCH L BRUNET S CHOPRA R CORDONNIER C DEWITTE T FAUSER A FERRANT A GARCIACONDE J JULIUSSON G KUBEL M MANNA AT MARTINEZRUBIO AM MUNDHENK P ORDEMANN R ORTEGA JJ POTTER M PRENTICE HG RAIMONDI R REMEZ K REUSSER P ROVIRA M RUSSELL J SELLESLAG D UDERZO C ZAUCHA JM
Citation: H. Link et al., CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT, Bone marrow transplantation, 21, 1998, pp. 479-479
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN INTENSIVELY PRETREATED PATIENTS WITH AML
Authors: LEIBLEIN S PONISCH W KURSCHNER D EDEL E ULRICH E KRAHL R BECKER C MANTOVANI L FRIEDRICH T HEROLD M FIEDLER F SCHWALBE V KUBEL M HEBIG W
Citation: S. Leiblein et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN INTENSIVELY PRETREATED PATIENTS WITH AML, British Journal of Haematology, 102(1), 1998, pp. 70-71
MOBILIZATION AND COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN 56 HEALTHY DONORS - A TWICE NORMAL VOLUME VERSUS A SINGLE LARGE-VOLUME SEPARATION
Authors: PONISCH W LEIBLEIN S EDEL E KUBEL M RIESE F WOLFF D HEBIG W
Citation: W. Ponisch et al., MOBILIZATION AND COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN 56 HEALTHY DONORS - A TWICE NORMAL VOLUME VERSUS A SINGLE LARGE-VOLUME SEPARATION, British Journal of Haematology, 102(1), 1998, pp. 72-73
CONTINUOUS-INFUSION OF MEROPENEM AS TREATMENT FOR INFECTIONS IN NEUTROPENIC PATIENTS
Authors: KURSCHNER D PONISCH W BECKER C WOLFF D KUBEL M HELBIG W
Citation: D. Kurschner et al., CONTINUOUS-INFUSION OF MEROPENEM AS TREATMENT FOR INFECTIONS IN NEUTROPENIC PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 94-94
TREATMENT OR GRAFT-VERSUS-HOST DISEASE WITH FK-506
Authors: WOLFF D BECKER C KURSCHNER D SKIBBE T PONISCH W KUBEL M HELBIG W
Citation: D. Wolff et al., TREATMENT OR GRAFT-VERSUS-HOST DISEASE WITH FK-506, British Journal of Haematology, 102(1), 1998, pp. 210-210
PRIMARY GUT-GVHD AFTER DISCONTINUATION OF IMMUNOSUPPRESSION
Authors: WOLFF D KURSCHNER D SKIBBE T BECKER C PONISCH W FRIEDRICH T KUBEL M HELBIG W
Citation: D. Wolff et al., PRIMARY GUT-GVHD AFTER DISCONTINUATION OF IMMUNOSUPPRESSION, British Journal of Haematology, 102(1), 1998, pp. 210-211
TREATMENT OF HIGH-RISK CHRONIC GVHD WITH FK-506, MYCOPHENOLATE-MOFETIL (MMF) AND METHYLPREDNISOLONE (MP)
Authors: WOLFF D KURSCHNER D SKIBBE T BECKER C PONISCH W KUBEL M HELBIG W
Citation: D. Wolff et al., TREATMENT OF HIGH-RISK CHRONIC GVHD WITH FK-506, MYCOPHENOLATE-MOFETIL (MMF) AND METHYLPREDNISOLONE (MP), British Journal of Haematology, 102(1), 1998, pp. 210-210
CHANGE OF MORPHOLOGICAL COMPLICATIONS AFTER BMT AND PBSCT
Authors: FRIEDRICH T WAHN G KUBEL M PONISCH W WOLFF D KRAHL R HELBIG W VOGELSANG G
Citation: T. Friedrich et al., CHANGE OF MORPHOLOGICAL COMPLICATIONS AFTER BMT AND PBSCT, British Journal of Haematology, 102(1), 1998, pp. 320-320
LOOK-OUT FOR PREDICTIVE MARKERS FOR PREMATURE RECOGNITION OF COMPLICATIONS IN PATIENTS WITH LEUKEMIA
Authors: SIEGEMUND A SCHEEL H KUBEL M HELBIG W POLEDNIA I
Citation: A. Siegemund et al., LOOK-OUT FOR PREDICTIVE MARKERS FOR PREMATURE RECOGNITION OF COMPLICATIONS IN PATIENTS WITH LEUKEMIA, Thrombosis and haemostasis, 1997, pp. 970-970
CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT
Authors: LINK H ARSENIEV L LJUNGMAN P ALESSANDRINO EP AMADORI S BANDINI G BEGUIN Y BRINCH L BRUNET S CHOPRA R CORDONNIER C DEWITTE T FAUSER A FERRANT AF GARCIACONDE J JULIUSSON G KUBEL M MANNA A MARTINEZRUBIO AM MUNDHENK P ORDEMANN R ORTEGA JJ POTTER M PRENTICE HP RAIMONDI R REMEZ K REUSSER P ROVIRA M RUSSELL J SELLESLAG D UDERZO C ZAUCHA JM
Citation: H. Link et al., CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT, Blood, 90(10), 1997, pp. 2424-2424
PERIPHERAL STEM-CELL MOBILIZATION AND AUTOGRAFTING IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) - THE LEIPZIG EXPERIENCE
Authors: KRAHL R PONISCH W KUBEL M SCHWENKE H LEIBLEIN S SCHULZE E SCHWARZER A HELBIG W
Citation: R. Krahl et al., PERIPHERAL STEM-CELL MOBILIZATION AND AUTOGRAFTING IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) - THE LEIPZIG EXPERIENCE, Blood, 88(10), 1996, pp. 2304-2304
SIDE-EFFECTS OF CONDITIONING REGIMENS PRIOR TO BONE-MARROW TRANSPLANTATION
Authors: FEYER P BUDACH V TITLBACH O KAMPRAD F KUBEL M WALTER A
Citation: P. Feyer et al., SIDE-EFFECTS OF CONDITIONING REGIMENS PRIOR TO BONE-MARROW TRANSPLANTATION, European journal of cancer, 31A, 1995, pp. 200-200
GUILLAIN-BARRE-SYNDROME, A POSSIBLE SIDE-EFFECT OF BUFFY COAT TRANSFUSION AND IFN-ALPHA THERAPY IN RELAPSED CML AFTER BONE-MARROW TRANSPLANTATION
Authors: SCHWARZER A SCHULZE E LEIBLEIN S KRAHL R KUBEL M BARTRAM C EDELMANN J SACK U HELBIG W
Citation: A. Schwarzer et al., GUILLAIN-BARRE-SYNDROME, A POSSIBLE SIDE-EFFECT OF BUFFY COAT TRANSFUSION AND IFN-ALPHA THERAPY IN RELAPSED CML AFTER BONE-MARROW TRANSPLANTATION, Annals of oncology, 6(6), 1995, pp. 617-617
Risultati: 1-21 |